Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
ESPR Quote, Financials, Valuation and Earnings
Last price:
$1.24
Seasonality move
:
-7.68%
Day range:
$1.11 - $1.27
52-week range:
$0.69 - $3.94
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.93x
P/B ratio:
--
Volume:
3.6M
Avg. volume:
3.2M
1-year change:
-52.67%
Market cap:
$245.8M
Revenue:
$332.3M
EPS (TTM):
-$0.80
Earnings Data
Next earnings date for ESPR
Aug 12
2025
Most recent earnings per share
-$0.21
Missed by $0.06
(May 6/2025)
Consensus Estimate
-$0.15
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ESPR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $93.4M | -- | -- | -$0.07 | -- |
| 08/12/2025 | Q2 | $62.5M | -- | -- | -$0.16 | -- |
| 05/06/2025 | Q1 | $54.2M | $65M | -$0.21 | -$0.15 | -$0.06 |
| 03/04/2025 | Q4 | $61.6M | $69.1M | -$0.11 | -$0.16 | $0.05 |
| 11/07/2024 | Q3 | $51.7M | $51.6M | -$0.15 | -$0.17 | $0.02 |
| 08/12/2024 | Q2 | $47.5M | $73.8M | -$0.33 | -$0.17 | -$0.16 |
| 05/07/2024 | Q1 | $83.9M | $137.7M | $0.34 | -$0.01 | $0.35 |
| 02/27/2024 | Q4 | $28.7M | $32.3M | -$0.50 | -$0.48 | -$0.02 |
| 11/07/2023 | Q3 | -- | -- | -$0.37 | -$0.42 | $0.05 |
| 08/01/2023 | Q2 | -- | -- | -$0.46 | -$0.63 | $0.17 |
| 05/09/2023 | Q1 | -- | -- | -$0.79 | -$0.66 | -$0.13 |
| 02/21/2023 | Q4 | -- | -- | -$0.76 | -$0.85 | $0.09 |
| 11/01/2022 | Q3 | -- | -- | -$0.81 | -$0.93 | $0.12 |
| 08/02/2022 | Q2 | -- | -- | -$1.05 | -$0.92 | -$0.13 |
| 05/03/2022 | Q1 | -- | -- | -$0.93 | -$1.04 | $0.11 |
| 02/22/2022 | Q4 | -- | -- | -$1.77 | -$2.29 | $0.52 |
| 11/02/2021 | Q3 | -- | -- | -$2.62 | -$2.80 | $0.18 |
| 08/03/2021 | Q2 | -- | -- | -$1.67 | -$1.85 | $0.18 |
| 05/04/2021 | Q1 | -- | -- | -$3.50 | -$2.72 | -$0.78 |
| 02/23/2021 | Q4 | -- | -- | -$3.89 | -$3.99 | $0.10 |
| 11/02/2020 | Q3 | -- | -- | -$3.07 | -$3.57 | $0.50 |
| 08/10/2020 | Q2 | -- | -- | $4.32 | $1.40 | $2.92 |
| 05/06/2020 | Q1 | -- | -- | -$2.84 | -$3.24 | $0.40 |
| 02/27/2020 | Q4 | -- | -- | -$2.26 | -$2.67 | $0.41 |
| 11/06/2019 | Q3 | -- | -- | -$2.52 | -$1.92 | -$0.60 |
| 08/08/2019 | Q2 | -- | -- | -$2.01 | -$1.82 | -$0.19 |
| 05/08/2019 | Q1 | -- | -- | $3.07 | $0.86 | $2.21 |
| 02/28/2019 | Q4 | -- | -- | -$2.24 | -$1.12 | -$1.12 |
| 11/01/2018 | Q3 | -- | -- | -$1.86 | -$1.64 | -$0.22 |
| 08/02/2018 | Q2 | -- | -- | -$1.71 | -$1.72 | $0.01 |
| 05/02/2018 | Q1 | -- | -- | -$1.73 | -$1.59 | -$0.14 |
| 02/20/2018 | Q4 | -- | -- | -$1.44 | -$1.77 | $0.33 |
| 11/07/2017 | Q3 | -- | -- | -$1.86 | -$1.77 | -$0.09 |
| 08/08/2017 | Q2 | -- | -- | -$1.92 | -$1.62 | -$0.30 |
| 05/04/2017 | Q1 | -- | -- | -$1.80 | -$1.46 | -$0.34 |
| 02/22/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/03/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 03/03/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
Esperion Therapeutics Earnings Questions
-
How Much did Esperion Therapeutics Generate in Revenue Last Quarter?
Esperion Therapeutics reported $65M worth of top line sales in its most recent quarter.
-
Did Esperion Therapeutics Beat Earnings Last Quarter?
Esperion Therapeutics announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.15 per share.
-
Is Esperion Therapeutics Profitable?
Esperion Therapeutics reported $33.5M that represents $0.17 per share over the last quarter.
-
What is the Analyst Consensus for Esperion Therapeutics EPS Next Year?
Esperion Therapeutics's earnings are forecast to decrease from -$0.28 per share to -$0.33 per share next year representing a decrease of -58.33%.
-
When is Esperion Therapeutics's Earnings Date?
Esperion Therapeutics's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
